About CSL Seqirus
CSL Seqirus is a leading provider of essential vaccines and pharmaceuticals. We have served Australia's healthcare needs for over a century and today we operate Australia's only local manufacturing facility for seasonal and pandemic influenza vaccine. Seqirus produces a range of unique medicines in the National Interest, and also in-licences a broad range of paediatric and adult vaccines and specialty pharmaceutical products including eye care products lkervis (ciclosporin 1mg/ml) and Cationorm (cationic nanoemulsion).
Cationorm® (cationic nanoemulsion) is a new preservative-free, hydrating and lubricating emulsion which protects the eye surface, reducing the discomfort and irritation of persistent dry eye caused by prolonged use of contact lenses, or environmental conditions.[1]. For product orders, please email: orders@goodopticalservices.com.au or 1800 814 963. Cationorm PBS Information: Cationorm® Multi Dose (10ml) Authority required (STREAMLINED) 6172. Refer to PBS Schedule for full authority information. Cationorm® (30 x 0.4ml) is not listed on the PBS.
lkervis® [ciclosporin 0.1% ophthalmic emulsion] is a ciclosporin emulsion for the treatment of severe keratitis in adults with dry eye disease that has not improved with artificial tears.[2]. Please review product information available at this virtual trade display. lkervis PBS Information: Authority Required. Refer to PBS Schedule for full information.
Please note the Seqirus team will be available at this booth during morning tea, lunch and afternoon breaks. If you have any additional questions regarding Seqirus products or would like to speak to a company representative, please email our Medical Information team at aunz.medicalinformation@seqirus.com.
References:
1. Cationorm Product Label
2. lkervis Product Information.
Seqirus (Australia) Pty Ltd. ABN 66 120 398 067. Melbourne, Australia. Seqirus Medical Information 1800 642 865.
Seqirus is a trademark of Seqirus UK Limited or its affiliates. IKERVIS and CATIONORM are registered trademarks of Santen S.A.S. and distributed by Seqirus (Australia) Pty Ltd under license from Santen Pharmaceutical Asia pte Ltd. Date of Preparation: February 2022. ANZ-Cati-22-0028
Cationorm® (cationic nanoemulsion) is a new preservative-free, hydrating and lubricating emulsion which protects the eye surface, reducing the discomfort and irritation of persistent dry eye caused by prolonged use of contact lenses, or environmental conditions.[1]. For product orders, please email: orders@goodopticalservices.com.au or 1800 814 963. Cationorm PBS Information: Cationorm® Multi Dose (10ml) Authority required (STREAMLINED) 6172. Refer to PBS Schedule for full authority information. Cationorm® (30 x 0.4ml) is not listed on the PBS.
lkervis® [ciclosporin 0.1% ophthalmic emulsion] is a ciclosporin emulsion for the treatment of severe keratitis in adults with dry eye disease that has not improved with artificial tears.[2]. Please review product information available at this virtual trade display. lkervis PBS Information: Authority Required. Refer to PBS Schedule for full information.
Please note the Seqirus team will be available at this booth during morning tea, lunch and afternoon breaks. If you have any additional questions regarding Seqirus products or would like to speak to a company representative, please email our Medical Information team at aunz.medicalinformation@seqirus.com.
References:
1. Cationorm Product Label
2. lkervis Product Information.
Seqirus (Australia) Pty Ltd. ABN 66 120 398 067. Melbourne, Australia. Seqirus Medical Information 1800 642 865.
Seqirus is a trademark of Seqirus UK Limited or its affiliates. IKERVIS and CATIONORM are registered trademarks of Santen S.A.S. and distributed by Seqirus (Australia) Pty Ltd under license from Santen Pharmaceutical Asia pte Ltd. Date of Preparation: February 2022. ANZ-Cati-22-0028